Fate Therapeutics, Inc. (FATE) has a MoatMap StockRank of 14/100 based on Quality (24/100), Value (42/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. Fate Therapeutics, Inc., a US healthcare company (biotech), lacks a direct and strong macro tailwind. Biotech companies are inherently speculative, R&D-driven, and do not typically exhibit the consistent quality compounder characteristics of high ROIC, asset-light operations, or durable moats required for a high-conviction position.